点眼薬（点眼用スポイト容器）の市場規模、シェア、動向分析レポート：タイプ別、薬剤タイプ別、治療タイプ別、地域別、セグメント別予測、2024年～2030年

点眼薬（点眼用スポイト容器）市場の成長と動向：

Grand View Research, Incの最新調査によると、世界の点眼薬市場規模は、2024年から2030年にかけてCAGR 6.01％で拡大し、2030年には200億2,000万米ドルに達すると予測されています。

緑内障、加齢黄斑変性症、眼症候群などの眼疾患の有病率が世界的に上昇し、スポイトによる効率的な治療に対する需要が急増しています。さらに、ドラッグデリバリー技術の進歩や防腐剤フリーの点眼薬のイントロダクションより、治療レジメンに対する患者のアドヒアランスが顕著に向上しています。例えば、防腐剤無添加の点眼薬は安全性が高く、ドライアイの患者に好まれているため、より頻繁に使用できると考えられています。

白内障、緑内障、ドライアイ症候群、アレルギーなどの眼疾患の増加は、点眼薬の需要を著しく高めています。例えば、National Glaucoma Researchの報告によると、300万人以上のアメリカ人が緑内障を患っており、そのうち270万人が40歳以上の高齢者の間で流行している開放隅角緑内障に罹患しています。このような有病率の急増は、世界の人口の高齢化と一致しており、これらの疾患の発生を増加させる一因となっています。その結果、点眼薬のような効果的な治療薬で、深刻化する目の健康課題に対処することが急務となっています。

最適な目の健康維持と定期的な眼科検診に対する意識の高まりが、点眼薬の需要を向上させています。このような積極的なアプローチは、眼科の問題をより早く治療するのに役立ち、眼科医療提供者や目薬製造企業が支援することを可能にしています。例えば、AlconやBausch+Lombのような企業は、様々な目の問題に対応する特別な目薬を製造しており、市場の成長を促進しています。

点眼薬市場レポートハイライト

• 2023年には、眼科疾患や眼感染症の有病率の上昇に加え、便利で費用対効果の高い点眼ソリューションに対する需要の高まりにより、保存型多剤点眼薬タイプが最大の収益シェアを占めました。
• 薬剤タイプに基づくと、処方箋に基づく治療を必要とする眼疾患の有病率が高く、スポイトを通して送達される特定の薬剤の需要を牽引しているため、処方薬セグメントは2023年に常に最大の収益シェアを占めています。
• 治療タイプ別では、ドライアイ分野が2023年に最大の売上シェアを占めました。これは、ドライアイ症候群の世界の有病率の上昇により、目の状態に対応するスポイトで送達される特殊な治療薬への需要が高まっているためです。
• 北米は、技術の進歩、眼疾患の有病率の増加、同地域における高齢化人口の増加により、2023年に市場で最大のシェアを占めました。
• 市場参入企業は、製品リーチを拡大し、多様な地域での入手可能性を向上させるために、いくつかの戦略的イニシアチブを採用しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 点眼薬市場の変数、動向および範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助的な市場見通し。
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 点眼薬市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 点眼薬市場：タイプの推定・動向分析

• 定義と範囲
• タイプの市場シェア、2018年および2030年
• セグメントダッシュボード
• タイプ別の世界の点眼薬市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第5章 点眼薬市場：薬剤タイプの推定・動向分析

• 定義と範囲
• 薬剤タイプの市場シェア、2018年および2030年
• セグメントダッシュボード
• 薬剤タイプ別の世界の点眼薬市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第6章 点眼薬市場：治療タイプの推定・動向分析

• 定義と範囲
• 治療タイプの市場シェア、2018年および2030年
• セグメントダッシュボード
• 治療タイプ別の世界の点眼薬市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第7章 点眼薬市場：地域の推定・動向分析

• 地域の市場シェア分析、2023年および2030年
• 地域の市場ダッシュボード
• 世界の地域の市場スナップショット
• 市場規模と予測動向分析、2018年から2030年
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 会社/競合の分類
  • イノベーター
• ベンダー情勢
  • AptarGroup, Inc
  • Silgan Dispensing Systems
  • Alcon plc
  • Pfizer
  • Bausch &Lomb Incorporated
  • Novartis AG
  • AbbVie Inc

List of Tables

• Table 1 List of regulatory bodies for different countries
• Table 2 Key companies' product launches
• Table 3 Key companies' merger and acquisitions
• Table 4 Key companies' collaboration
• Table 5 Other strategic initiatives of companies
• Table 6 North America ophthalmic eye dropper market, by country, 2018 - 2030 (USD Million)
• Table 7 North America ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 8 North America ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 9 North America ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 10 U.S. ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 11 U.S. ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 12 U.S. ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 13 Canada ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 14 Canada ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 15 Canada ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 16 Europe ophthalmic eye dropper market, by country, 2018 - 2030 (USD Million)
• Table 17 Europe ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 18 Europe ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 19 Europe ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 20 UK ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 21 UK ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 22 UK ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 23 Germany ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 24 Germany ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 25 Germany ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 26 France ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 27 France ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 28 France ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 29 Italy ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 30 Italy ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 31 Italy ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 32 Spain ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 33 Spain ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 34 Spain ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 35 Norway ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 36 Norway ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 37 Norway ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 38 Sweden ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 39 Sweden ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 40 Sweden ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 41 Denmark ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 42 Denmark ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 43 Denmark ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 44 Asia Pacific ophthalmic eye dropper market, by country, 2018 - 2030 (USD Million)
• Table 45 Asia Pacific ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 46 Asia Pacific ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 48 Japan ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 49 Japan ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 50 Japan ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 51 China ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 52 China ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 53 China ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 54 India ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 55 India ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 56 India ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 57 Australia ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 58 Australia ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 59 Australia ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 60 South Korea ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 61 South Korea ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 62 South Korea ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 63 Thailand ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 64 Thailand ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 65 Thailand ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 66 Latin America ophthalmic eye dropper market, by country, 2018 - 2030 (USD Million)
• Table 67 Latin America ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 68 Latin America ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 69 Latin America ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 70 Brazil ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 71 Brazil ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 72 Brazil ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 73 Mexico ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 74 Mexico ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 75 Mexico ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 76 Argentina ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 77 Argentina ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 78 Argentina ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa ophthalmic eye dropper market, by country, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 83 South Africa ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 84 South Africa ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 85 South Africa ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 89 UAE ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 90 UAE ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 91 UAE ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
• Table 92 Kuwait ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
• Table 93 Kuwait ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
• Table 94 Kuwait ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Ophthalmic eye dropper market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement process
• Fig. 4 Primary research pattern
• Fig. 5 Ophthalmic eye dropper market snapshot, 2023 (USD Million)
• Fig. 6 Segment snapshot, USD Million
• Fig. 7 Competitive landscape snapshot
• Fig. 8 Penetration & growth prospect mapping, by product
• Fig. 9 Market driver analysis (Current & future impact)
• Fig. 10 Market restraint analysis (Current & future impact)
• Fig. 11 Ophthalmic eye dropper market, type outlook key takeaways (USD Million)
• Fig. 12 Ophthalmic eye dropper market: type movement analysis (USD Million), 2023 & 2030
• Fig. 13 Unidose eye droppers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 14 Preserved multi-dose eye droppers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 15 Preservative-free multi-dose eye droppers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 16 Ophthalmic eye dropper market, drug type outlook key takeaways (USD Million)
• Fig. 17 Ophthalmic eye dropper market: Drug type movement analysis (USD Million), 2023 & 2030
• Fig. 18 Prescription drugs market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 OTC drugs market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Ophthalmic eye dropper market, treatment type outlook key takeaways (USD Million)
• Fig. 21 Ophthalmic eye dropper market: Treatment type movement analysis (USD Million), 2023 & 2030
• Fig. 22 Dry eye market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Glaucoma market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Allergies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Conjunctivitis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Ophthalmic eye dropper market : Regional key takeaways (USD Million)
• Fig. 28 Ophthalmic eye dropper market: Regional outlook, 2023 & 2030, USD Million
• Fig. 29 North America ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 U.S. ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Canada ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Europe ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 UK ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Germany ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 France ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Spain ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Italy ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Sweden ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Norway ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Denmark ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Asia Pacific ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 China ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Japan ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 India ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 South Korea ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Australia ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Thailand ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Latin America ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Brazil ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Mexico ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Argentina ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Middle East and Africa ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 South Africa ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Saudi Arabia ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 UAE ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Kuwait ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 List of key emerging company's/technology disruptors/innovators

Ophthalmic Eye Dropper Market Growth & Trends:

The global ophthalmic eye dropper market size is anticipated to reach USD 20.02 billion by 2030, expanding at a CAGR of 6.01% from 2024 to 2030 according to a new study by Grand View Research, Inc. The rising prevalence of eye disorders such as glaucoma, age-related macular degeneration, and eye syndrome among the aging population worldwide has surged the demand for efficient treatments delivered through eye droppers. Moreover, advancements in drug delivery technologies and the introduction of preservative-free eye drops have notably improved patient adherence to treatment regimens. For instance, preservative-free drops are considered safer and preferred by individuals with dry eyes, thus allowing more frequent use.

The rise in eye conditions such as cataracts, glaucoma, dry eye syndrome, and allergies has significantly bolstered the demand for ophthalmic eye drops. For instance, as reported by the National Glaucoma Research, over 3 million Americans live with glaucoma, out of which 2.7 million are affected by the prevalent open-angle glaucoma among those aged 40 and older. This surge in prevalence aligns with the aging global population, contributing to the increasing occurrence of these conditions. Consequently, there's a pressing necessity for effective treatments like eye drops to address these escalating eye health challenges.

The increased awareness about maintaining optimal eye health and regular eye check-ups has improved the demand for ophthalmic eye drops. This proactive approach helps treat ophthalmic issues quicker which allows eye care providers and eye drops manufacturing companies to assist. For instance, companies like Alcon and Bausch + Lomb have made special eye drops for different eye problems, thereby fueling the market growth.

Ophthalmic Eye Dropper Market Report Highlights:

• In 2023, the preserved multi-dose eye dropper type segment accounted for the largest revenue share due to the rising prevalence of ophthalmic diseases and eye infections, coupled with the increased demand for convenient and cost-effective eye drop solutions
• Based on drug type, the prescription drugs segment has always accounted for the largest revenue share in 2023, due to the high prevalence of eye disorders requiring prescription-based treatments, driving the demand for specific medications delivered through eye droppers
• Based on treatment type, the dry eye segment accounted for the largest revenue share in 2023, due to rising prevalence of dry eye syndrome globally, inspiring a higher demand for specialized treatments delivered through eye droppers catering to the eye condition
• North America held the largest share of the market in 2023 due to technological advancements and increasing prevalence of eye disorders, coupled with a growing aging population in the region
• Market players adopt several strategic initiatives to increase the product reach and improve availability in diverse geographic areas

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Type
  • 1.1.2. Drug Type
  • 1.1.3. Treatment
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for Primary Interviews in North America
    • 1.3.5.2. Data for Primary Interviews in Europe
    • 1.3.5.3. Data for Primary Interviews in Asia Pacific
    • 1.3.5.4. Data for Primary Interviews in Latin America
    • 1.3.5.5. Data for Primary Interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Drug Type
  • 2.2.3. Treatment Type
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Ophthalmic Eye Dropper Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of eye disorders
    • 3.2.1.2. Technological advancements in drug delivery systems
    • 3.2.1.3. Aging population and lifestyle changes
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Limited patient compliance
• 3.3. Ophthalmic Eye Dropper Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Ophthalmic Eye Dropper Market: Type Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Unidose eye droppers
  • 4.1.2. Preserved multi-dose eye droppers
  • 4.1.3. Preservative-free multi-dose eye droppers
• 4.2. Type Market Share, 2018 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Ophthalmic Eye Dropper Market by Type Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5.1. Unidose eye droppers
    • 4.5.1.1. Unidose eye Droppers Market Estimates and Forecast 2018 to 2030 (USD Million)
  • 4.5.2. Preserved multi-dose eye droppers
    • 4.5.2.1. Preserved multi-dose eye droppers market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.3. Preservative-free multi-dose eye droppers
    • 4.5.3.1. Preservative-free multi-dose eye Droppers Market Estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Ophthalmic Eye Dropper Market: Drug Type Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Prescription drugs
  • 5.1.2. OTC drugs
• 5.2. Drug Type Market Share, 2018 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Ophthalmic Eye Dropper Market by Drug Type Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5.1. Prescription drugs
    • 5.5.1.1. Prescription drugs market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. OTC drugs
    • 5.5.2.1. OTC drugs market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Ophthalmic Eye Dropper Market: Treatment Type Estimates & Trend Analysis

• 6.1. Definitions and Scope
  • 6.1.1. Dry Eye
  • 6.1.2. Glaucoma
  • 6.1.3. Allergies
  • 6.1.4. Conjunctivitis
  • 6.1.5. Others
• 6.2. Treatment Type Market Share, 2018 & 2030
• 6.3. Segment Dashboard
• 6.4. Global Ophthalmic Eye Dropper Market by Treatment Type Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5.1. Dry Eye
    • 6.5.1.1. Dry eye market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.2. Glaucoma
    • 6.5.2.1. Glaucoma market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.3. Allergies
    • 6.5.3.1. Allergies market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.4. Conjunctivitis
    • 6.5.4.1. Conjunctivitis market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.5. Others
    • 6.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Ophthalmic Eye Dropper Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Competitive scenario
    • 7.5.1.3. Regulatory framework
    • 7.5.1.4. Reimbursement scenario
    • 7.5.1.5. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. Canada market estimates and forecast, 2018 - 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Competitive scenario
    • 7.6.1.3. Regulatory framework
    • 7.6.1.4. Reimbursement scenario
    • 7.6.1.5. UK market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. France market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Regulatory framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Competitive scenario
    • 7.6.5.3. Regulatory framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Competitive scenario
    • 7.6.6.3. Regulatory framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Competitive scenario
    • 7.6.7.3. Regulatory framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Competitive scenario
    • 7.6.8.3. Regulatory framework
    • 7.6.8.4. Reimbursement scenario
    • 7.6.8.5. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement scenario
    • 7.7.1.5. Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. China market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. India market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Competitive scenario
    • 7.7.6.3. Regulatory framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive scenario
    • 7.8.1.3. Regulatory framework
    • 7.8.1.4. Reimbursement scenario
    • 7.8.1.5. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.2. Mexico
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive scenario
    • 7.8.3.3. Regulatory framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Competitive scenario
    • 7.9.1.3. Regulatory framework
    • 7.9.1.4. Reimbursement scenario
    • 7.9.1.5. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Competitive scenario
    • 7.9.2.3. Regulatory framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Competitive scenario
    • 7.9.3.3. Regulatory framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Competitive scenario
    • 7.9.4.3. Regulatory framework
    • 7.9.4.4. Reimbursement scenario
    • 7.9.4.5. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2023
  • 8.3.4. AptarGroup, Inc
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Silgan Dispensing Systems
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Alcon plc
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Pfizer
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Bausch & Lomb Incorporated
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Novartis AG
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. AbbVie Inc
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives